Inari Medical Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Inari Medical, Inc. (NARI) Tops Q3 EPS by 16c, Revenues Beat
November 12, 2020 4:02 PM ESTInari Medical, Inc. (NASDAQ: NARI) reported Q3 EPS of $0.12, $0.16 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $38.7 million versus the consensus estimate of $26.53 million.
Third Quarter Highlights:
Record procedure volume in Q3, treated over 3,700 patientsReported revenue of $38.7 million in... More